PBYI
NASDAQ · Biotechnology
Puma Biotechnology Inc
$9.59
-0.01 (-0.10%)
Open$9.68
Previous Close$9.60
Day High$9.76
Day Low$9.55
52W High$9.74
52W Low$4.30
Volume—
Avg Volume269.0K
Market Cap491.42M
P/E Ratio20.15
EPS$0.48
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
-43.2% upside
Current
$9.59
$9.59
Target
$5.45
$5.45
$2.99
$5.45 avg
$6.80
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 231.51M | 231.40M | 42.11M |
| Net Income | 31.54M | 28.37M | 7.89M |
| Profit Margin | 13.6% | 12.9% | 18.7% |
| EBITDA | 48.90M | 46.43M | 13.15M |
| Free Cash Flow | — | — | 4.76M |
| Rev Growth | +0.1% | +0.1% | +7.6% |
| Debt/Equity | 0.17 | 0.17 | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |